Literature DB >> 15057951

Culture of endothelial cells isolated from maternal blood using anti-CD105 and CD133.

Hélène A Elicha Gussin1, Arun K Sharma, Sherman Elias.   

Abstract

OBJECTIVES: We hypothesized that fetal cells in maternal blood that do not respond to hematopoietic culture conditions represent endothelial cells. We investigated whether endothelial progenitor cells of fetal origin may be selected from maternal blood on the basis of their expression of CD133 or CD105 and expanded in culture.
METHODS: Peripheral blood mononuclear cells from 16 pregnant women (gestational age: 11 to 24 weeks) were labeled with magnetic beads coupled to anti-CD133 or anti-CD105. Selection of labeled cells was performed using MACS. Resulting CD133+, CD105+, and CD133-/CD105- cell fractions were placed in culture in conditions favoring endothelial cells for 7 days (positive fractions) to 30 days (depleted fractions). Cells from women carrying male fetuses were analyzed by conventional PCR (SRY primers) for detection of male cells.
RESULTS: Expansion of cells isolated from all subjects occurred in each of the cell fractions. No PCR products consistent with the presence of male cells were detected in women carrying male fetuses.
CONCLUSION: CD133+ and CD105+ cells isolated from maternal blood can be expanded in vitro under endothelial conditions. These cells appear to be of maternal, rather than fetal, origin. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15057951     DOI: 10.1002/pd.832

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  2 in total

1.  Maternal endothelial progenitor colony-forming units with macrophage characteristics are reduced in preeclampsia.

Authors:  Carol Lin; Augustine Rajakumar; Daniel A Plymire; Vivek Verma; Nina Markovic; Carl A Hubel
Journal:  Am J Hypertens       Date:  2009-06-04       Impact factor: 2.689

2.  Differential expression profile analysis of DNA damage repair genes in CD133+/CD133- colorectal cancer cells.

Authors:  Yuhong Lu; Xin Zhou; Qingliang Zeng; Daishun Liu; Changwu Yue
Journal:  Oncol Lett       Date:  2017-06-19       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.